No. J1720 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What is the Medicare payment limit for J1720?

$23.149 per 100 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J1720 J-Code: Solu-Cortef

In short

J1720 is the HCPCS Level II code for injection, hydrocortisone sodium succinate, up to 100 mg. CMS assigns NDCs for Hydrocortisone Sodium Succinate and Solu-Cortef to it. The Medicare Part B payment limit is $23.149 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ1720

Billing unitSee descriptor

Descriptor: Injection, hydrocortisone sodium succinate, up to 100 mg
Short descriptor: Hydrocortisone sodium succ i
Code set: HCPCS Level II, maintained by CMS
Effective: Jan 1, 1997

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$23.149

Per100 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

HCPCS units

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the units to build the claim line.

NDCs billed under J1720

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 12 NDCs to J1720 for Hydrocortisone Sodium Succinate and Solu-Cortef. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J1720 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Hydrocortisone Sodium Succinate	60505-6411-00	Apotex Corp	1	1
Hydrocortisone Sodium Succinate	69097-0004-67	Cipla USA, Inc.	1	1
Hydrocortisone Sodium Succinate	70710-1907-01	Zydus Pharmaceuticals (USA) Inc.	1	1
Solu-Cortef	00009-0005-01	Pfizer Inc	1	10
Solu-Cortef	00009-0011-03	Pfizer Inc	1	1
Solu-Cortef	00009-0011-04	Pfizer Inc	25 × 1	25
Solu-Cortef	00009-0013-05	Pfizer Inc	1	3
Solu-Cortef	00009-0013-06	Pfizer Inc	25 × 1	75
Solu-Cortef	00009-0016-12	Pfizer Inc	1	5
Solu-Cortef	00009-0825-01	Pfizer Inc	1	1
Solu-Cortef	51662-1261-01	HF Acquisition Co. LLC, DBA HealthFirst	1	1
Solu-Cortef	51662-1262-01	HF Acquisition Co. LLC, DBA HealthFirst	1	3

J1720: common questions

Is J1720 a CPT code?: No. J1720 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J1720?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 12 NDCs under J1720, for Hydrocortisone Sodium Succinate and Solu-Cortef. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J1720?: $23.149 per 100 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J1720 — Injection, hydrocortisone sodium succinate, up to 100 mg